Insider · CIK 0001669081
Noel Bertram Watson
directorcfocooofficer
Files at LZ (LEGALZOOM.COM, INC.), AFRM (Affirm Holdings, Inc.). First filing Dec 18, 2024, latest Nov 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $1.3M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
LZ: LEGALZOOM.COM, INC.
LZOct 9, 2026 · close 5.98
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
AFRM: Affirm Holdings, Inc.
AFRMOct 9, 2026 · close 80.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | LEGALZOOM.COM, INC. | $143k 15,000 shares | -1% | - | |
| 35Weak | LEGALZOOM.COM, INC. | $503k 45,455 shares | -3% | - | |
| 28Weak | LEGALZOOM.COM, INC. | $162k 15,000 shares | -1% | - | |
| 6Weak | Affirm Holdings, Inc. | $152k 2,500 shares | -6% | +70% from low-25% from high | |
| 13Weak | Affirm Holdings, Inc. | $114k 2,500 shares | -6% | +25% from low-41% from high | |
| 22Weak | Affirm Holdings, Inc. | $180k 2,500 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | AFRM Affirm Holdings, Inc. | AGrant or award Class A Common Stock | +3,579 | $0.00 | $0 | 40,076 | Dec 17, 2025 |
| Nov 15, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock10b5-1 | -318,901 | $10.01 | $3.2M | 1,566,582 | Nov 18, 2025 |
| Nov 18, 2025 | LZ LEGALZOOM.COM, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $9.56 | $143k | 1,551,582 | Nov 18, 2025 |
| Sep 17, 2025 | LZ LEGALZOOM.COM, INC. | AGrant or award Common Stock | +208,031 | $0.00 | $0 | 1,884,457 | Sep 18, 2025 |
| Sep 17, 2025 | LZ LEGALZOOM.COM, INC. | MOption exercise Performance Rights (November 2024)derivative | -208,031 | $0.00 | $0 | 1,144,172 | Sep 18, 2025 |
| Aug 22, 2025 | LZ LEGALZOOM.COM, INC. | SOpen-market sale Common Stock10b5-1 | -18,136 | $11.03 | $200k | 1,703,745 | Aug 26, 2025 |
| Aug 25, 2025 | LZ LEGALZOOM.COM, INC. | SOpen-market sale Common Stock10b5-1 | -27,319 | $11.07 | $303k | 1,676,426 | Aug 26, 2025 |
| Aug 15, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock10b5-1 | -56,216 | $10.72 | $603k | 1,736,881 | Aug 19, 2025 |
| Aug 18, 2025 | LZ LEGALZOOM.COM, INC. | SOpen-market sale Common Stock10b5-1 | -15,000 | $10.81 | $162k | 1,721,881 | Aug 19, 2025 |
| Jul 9, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock | -48,516 | $8.97 | $435k | 1,793,097 | Jul 10, 2025 |
| Jun 16, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,271 | $60.50 | $77k | 37,726 | Jun 17, 2025 |
| Jun 16, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,229 | $61.23 | $75k | 36,497 | Jun 17, 2025 |
| May 15, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock | -56,213 | $9.20 | $517k | 1,841,613 | May 16, 2025 |
| Mar 17, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -500 | $43.56 | $22k | 40,997 | Mar 19, 2025 |
| Mar 17, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -535 | $44.74 | $24k | 40,462 | Mar 19, 2025 |
| Mar 17, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -200 | $45.73 | $9,146 | 40,262 | Mar 19, 2025 |
| Mar 17, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -767 | $46.70 | $36k | 39,495 | Mar 19, 2025 |
| Mar 17, 2025 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -498 | $47.73 | $24k | 38,997 | Mar 19, 2025 |
| Feb 23, 2025 | LZ LEGALZOOM.COM, INC. | MOption exercise Common Stock | +312,047 | $0.00 | $0 | 1,895,826 | Feb 25, 2025 |
| Feb 23, 2025 | LZ LEGALZOOM.COM, INC. | MOption exercise Performance Rights (November 2024)derivative | -312,047 | $0.00 | $0 | 1,352,203 | Feb 25, 2025 |
| Feb 15, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock | -25,908 | $9.18 | $238k | 1,583,779 | Feb 19, 2025 |
| Feb 6, 2025 | LZ LEGALZOOM.COM, INC. | AGrant or award Common Stock | +300,120 | $0.00 | $0 | 1,661,147 | Feb 10, 2025 |
| Feb 6, 2025 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock | -51,460 | $9.23 | $475k | 1,609,687 | Feb 10, 2025 |
| Dec 16, 2024 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -400 | $70.27 | $28k | 43,597 | Dec 18, 2024 |
| Dec 16, 2024 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -600 | $71.57 | $43k | 42,997 | Dec 18, 2024 |
| Dec 16, 2024 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,000 | $72.53 | $73k | 41,997 | Dec 18, 2024 |
| Dec 16, 2024 | AFRM Affirm Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -500 | $73.11 | $37k | 41,497 | Dec 18, 2024 |
| Dec 10, 2024 | AFRM Affirm Holdings, Inc. | AGrant or award Class A Common Stock | +3,015 | $0.00 | $0 | 43,997 | Dec 12, 2024 |
| Nov 15, 2024 | LZ LEGALZOOM.COM, INC. | FTax withholding Common Stock | -41,983 | $7.73 | $325k | 944,964 | Nov 19, 2024 |
| Nov 15, 2024 | LZ LEGALZOOM.COM, INC. | AGrant or award Common Stock | +416,063 | $0.00 | $0 | 1,361,027 | Nov 19, 2024 |
| Nov 15, 2024 | LZ LEGALZOOM.COM, INC. | AGrant or award Performance Rights (November 2024)derivative | +416,063 | $0.00 | $0 | 416,063 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.